- Home
- Publications
- Publication Search
- Publication Details
Title
Nintedanib for the treatment of idiopathic pulmonary fibrosis
Authors
Keywords
-
Journal
EXPERT OPINION ON PHARMACOTHERAPY
Volume 19, Issue 2, Pages 167-175
Publisher
Informa UK Limited
Online
2018-01-12
DOI
10.1080/14656566.2018.1425681
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Idiopathic Pulmonary Fibrosis: Molecular Endotypes of Fibrosis Stratifying Existing and Emerging Therapies
- (2017) Daniele Magnini et al. RESPIRATION
- Long-term treatment of patients with idiopathic pulmonary fibrosis with nintedanib: results from the TOMORROW trial and its open-label extension
- (2017) Luca Richeldi et al. THORAX
- Effect of pirfenidone on mortality: pooled analyses and meta-analyses of clinical trials in idiopathic pulmonary fibrosis
- (2017) Steven D Nathan et al. Lancet Respiratory Medicine
- Role of pirfenidone in the management of pulmonary fibrosis
- (2017) Keith Meyer et al. Therapeutics and Clinical Risk Management
- Efficacy of Nintedanib in Idiopathic Pulmonary Fibrosis across Prespecified Subgroups in INPULSIS
- (2016) Ulrich Costabel et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Pharmacokinetic Properties of Nintedanib in Healthy Volunteers and Patients With Advanced Cancer
- (2016) Claudia Dallinger et al. JOURNAL OF CLINICAL PHARMACOLOGY
- First Data on Efficacy and Safety of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis and Forced Vital Capacity of ≤50 % of Predicted Value
- (2016) Wim A. Wuyts et al. LUNG
- Pirfenidone, nintedanib and N-acetylcysteine for the treatment of idiopathic pulmonary fibrosis: A systematic review and meta-analysis
- (2016) Paola Rogliani et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Insights from the German Compassionate Use Program of Nintedanib for the Treatment of Idiopathic Pulmonary Fibrosis
- (2016) Francesco Bonella et al. RESPIRATION
- Nintedanib in patients with idiopathic pulmonary fibrosis: Combined evidence from the TOMORROW and INPULSIS® trials
- (2016) Luca Richeldi et al. RESPIRATORY MEDICINE
- Pharmacological management of IPF
- (2016) Raphael Borie et al. RESPIROLOGY
- Nintedanib in Japanese patients with idiopathic pulmonary fibrosis: A subgroup analysis of the INPULSIS® randomized trials
- (2016) Arata Azuma et al. RESPIROLOGY
- Nintedanib in patients with idiopathic pulmonary fibrosis and preserved lung volume
- (2016) Martin Kolb et al. THORAX
- Early lung surveillance of cystic fibrosis: what have we learnt?
- (2016) Rachel E Foong et al. Expert Review of Respiratory Medicine
- Nintedanib (OFEV) in the treatment of idiopathic pulmonary fibrosis
- (2016) Jun Fukihara et al. Expert Review of Respiratory Medicine
- An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline
- (2015) Ganesh Raghu et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Switching to nintedanib after discontinuation of pirfenidone due to adverse events in IPF
- (2015) Katrin Milger et al. EUROPEAN RESPIRATORY JOURNAL
- The role of tyrosine kinases in the pathogenesis of idiopathic pulmonary fibrosis
- (2015) Friedrich Grimminger et al. EUROPEAN RESPIRATORY JOURNAL
- Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis
- (2015) Lutz Wollin et al. EUROPEAN RESPIRATORY JOURNAL
- Nintedanib: examining the development and mechanism of action of a novel triple angiokinase inhibitor
- (2015) Martin Reck Expert Review of Anticancer Therapy
- Nintedanib: From Discovery to the Clinic
- (2015) Gerald J. Roth et al. JOURNAL OF MEDICINAL CHEMISTRY
- Nintedanib: A Review of Its Use as Second-Line Treatment in Adults with Advanced Non-Small Cell Lung Cancer of Adenocarcinoma Histology
- (2015) Sohita Dhillon Targeted Oncology
- Nintedanib in the treatment of idiopathic pulmonary fibrosis
- (2015) Mariano E. Mazzei et al. Therapeutic Advances in Respiratory Disease
- Safety and pharmacokinetics of nintedanib and pirfenidone in idiopathic pulmonary fibrosis
- (2014) Takashi Ogura et al. EUROPEAN RESPIRATORY JOURNAL
- A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
- (2014) Talmadge E. King et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
- (2014) Luca Richeldi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Idiopathic pulmonary fibrosis in US Medicare beneficiaries aged 65 years and older: incidence, prevalence, and survival, 2001–11
- (2014) Ganesh Raghu et al. Lancet Respiratory Medicine
- Combination therapy: the future of management for idiopathic pulmonary fibrosis?
- (2014) Wim A Wuyts et al. Lancet Respiratory Medicine
- An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management
- (2011) Ganesh Raghu et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Efficacy of a Tyrosine Kinase Inhibitor in Idiopathic Pulmonary Fibrosis
- (2011) Luca Richeldi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pharmacokinetics and metabolism of BIBF 1120 after oral dosing to healthy male volunteers
- (2011) Peter Stopfer et al. XENOBIOTICA
- Clinical Course and Prediction of Survival in Idiopathic Pulmonary Fibrosis
- (2010) Brett Ley et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Targeting non-malignant disorders with tyrosine kinase inhibitors
- (2010) Friedrich Grimminger et al. NATURE REVIEWS DRUG DISCOVERY
- The pathogenesis of idiopathic pulmonary fibrosis
- (2010) William R. Coward et al. Therapeutic Advances in Respiratory Disease
- Design, Synthesis, and Evaluation of Indolinones as Triple Angiokinase Inhibitors and the Discovery of a Highly Specific 6-Methoxycarbonyl-Substituted Indolinone (BIBF 1120)
- (2009) Gerald J. Roth et al. JOURNAL OF MEDICINAL CHEMISTRY
- BIBF 1120: Triple Angiokinase Inhibitor with Sustained Receptor Blockade and Good Antitumor Efficacy
- (2008) F. Hilberg et al. CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search